Member Info for LarryWildman

Up 50% now in 2 weeks 2015 top pick for me, great bod, great business model and ton of II's holding most of the stock

Cheers, a year off the bb... God to be back

Seems a reasonable punt now. News in January stated by the bod

Full ask again paid ... Decent trades coming in

Bid creeping on on price paid.. Can see a reversal here today as it's digested Put it this was far better market than we were in

$4.2 billion....this is an exciting phase in our development of the business roll-out so we are looking forward to working with the new team and delivering on our plans for the IONA® Test.”

Wakey wakey ;)))) Much better area for us to move

Ha...I'm with barx... It's not trading online with everbody...phone trade only until they have it up and running. Dyor novice

It moves quick as does the book.... Good luck chaps

Strengthen as day goes on. Interesting day ahead! :))))

No... Holding as new area. Need to read up opposed to nee jerk. Got to dash and running out.

Cheers Scarlett... Same on barx. Nobody can trade.... Running out...later all but interesting indeed and lots of reading

It's not even running on barx on telephone trade!

Could be an interesting ride

Steve, do tell us what you know about biotech ? Look at trp this morning. AR has a credible track record you doof ... Rescued this company and setting us in a new direction.

Premaitha employs next generation sequencing technology to develop, manufacture and sell molecular diagnostic products intended to have a major beneficial impact on human health. Its first product - the IONA® test - is designed to take advantage of a very significant change in the field of pre-natal medicine which is creating a multi-billion pound market for improved pre-natal screening tests. Subsequent products are expected to address other important health challenges such as cancer screening and monitoring and personalised healthcare. Further information about Premaitha can be found at www.premaitha.com.

"As Premaitha builds and commercialises the IONA® Test, the Company is not only building a valuable in vitro diagnostic product in its own right but also establishing a template for creating valuable diagnostic content on third parties' next generation sequencing systems. There are many other potential clinical applications of next generation sequencing such as early detection of cancer and prediction of response to therapy. Premaitha's plan is to take early stage discoveries and translate them into clinically useful diagnostic products that can be widely used to benefit human health. This is an exciting phase in our development of the business roll-out and we are looking forward to working with the new team and delivering on our plans for the IONA® Test."

develop and commercialise the IONA®Test and provide capital for the Enlarged Group's sales and marketing initiative in a global market for pre-natal testing estimated at $4.2 billion.

Huge newssssssss

Could do with cheering up... News would be welcome now